Lesly Giovanna Maldonado-Burbano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lesly Giovanna Maldonado-Burbano has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Jose Carvajal-Mazuera
Fundacion Universitaria Autonoma de las Americas. Pereira, Colombia
1 shared publication - Brayan Franchesco Nocua Martínez
Universidad de Santander
1 shared publication - Danuil Julián Melo Ascanio
Universidad Metropolitana
1 shared publication - Ivonne Lorena Reina Fonseca
Fundación Universitaria Juan N. Corpas
1 shared publication - Juan Camilo Arias-Pérez
Universidad Cooperativa de Colombia
1 shared publication - Maria Alejandra Palacios-Rodríguez
Universidad De Manizales
1 shared publication
Latest Publications
- Open Access
- 15 September 2026
- Published by Asociación Civil Universidad de Ciencias y Humanidades in Health Care & Global Health
- Vol. 3 (10) , 252
Perioperative Considerations in Patients with Type 2 Diabetes Mellitus: A Narrative Review
Type 2 diabetes mellitus (T2DM) poses increasing perioperative challenges due to the widespread use of modern antidiabetic therapies with cardiometabolic, renal, and weight-related benefits, but also specific anesthetic and metabolic safety implications. This narrative review integrated clinical, pharmacological, and perioperative evidence on glucagon-like peptide-1 receptor agonists (GLP-1RA), dual GIP/GLP-1 agonists, and sodium-glucose cotransporter-2 inhibitors (SGLT2i). GLP-1RA and dual GIP/GLP-1 agonists are associated with delayed gastric emptying and increased residual gastric content, although their relationship with clinically significant pulmonary aspiration remains uncertain. Gastric ultrasound may support individualized risk stratification in selected settings. Conversely, SGLT2i are linked to euglycemic diabetic ketoacidosis, particularly during fasting, surgery, infection, dehydration, or carbohydrate restriction, requiring preoperative discontinuation, metabolic surveillance, and delayed reinitiation until clinical stability, euvolemia, and oral tolerance are achieved. Perioperative care in T2DM should move beyond a glucose-centered approach and incorporate medication reconciliation, multidisciplinary assessment, and individualized decision-making based on anesthetic, metabolic, and surgical risk. Keywords: Diabetes Mellitus, Type 2; Perioperative Care; Glucagon-Like Peptide-1 Receptor Agonists; Sodium-Glucose Transporter 2 Inhibitors; Diabetic Ketoacidosis (Source: MeSH, NLM).
- 15 September 2026
- Published by Asociación Civil Universidad de Ciencias y Humanidades in Health Care & Global Health
- Vol. 3 (10) , 252
Open AccessPerioperative Considerations in Patients with Type 2 Diabetes Mellitus: A Narrative Review
Type 2 diabetes mellitus (T2DM) poses increasing perioperative challenges due to the widespread use of modern antidiabetic therapies with cardiometabolic, renal, and weight-related benefits, but also specific anesthetic and metabolic safety implications. This narrative review integrated clinical, pharmacological, and perioperative evidence on glucagon-like peptide-1 receptor agonists (GLP-1RA), dual GIP/GLP-1 agonists, and sodium-glucose cotransporter-2 inhibitors (SGLT2i). GLP-1RA and dual GIP/GLP-1 agonists are associated with delayed gastric emptying and increased residual gastric content, although their relationship with clinically significant pulmonary aspiration remains uncertain. Gastric ultrasound may support individualized risk stratification in selected settings. Conversely, SGLT2i are linked to euglycemic diabetic ketoacidosis, particularly during fasting, surgery, infection, dehydration, or carbohydrate restriction, requiring preoperative discontinuation, metabolic surveillance, and delayed reinitiation until clinical stability, euvolemia, and oral tolerance are achieved. Perioperative care in T2DM should move beyond a glucose-centered approach and incorporate medication reconciliation, multidisciplinary assessment, and individualized decision-making based on anesthetic, metabolic, and surgical risk. Keywords: Diabetes Mellitus, Type 2; Perioperative Care; Glucagon-Like Peptide-1 Receptor Agonists; Sodium-Glucose Transporter 2 Inhibitors; Diabetic Ketoacidosis (Source: MeSH, NLM).